Resiliency Roadmap Update: US FDA Exceeds FY 2021 Inspection Projections

While better than one its ‘best case’ scenarios, FDA has completed just 31% of 15,514 domestic surveillance inspections planned for FY 2021, applications are still being delayed, and foreign inspections have for the most part yet to be tackled.